Open access chemical and clinical probes to support drug discovery

  • Edwards A
  • Bountra C
  • Kerr D
 et al. 
  • 96

    Readers

    Mendeley users who have this article in their library.
  • 83

    Citations

    Citations of this article.

Abstract

Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Aled M. Edwards

  • Chas Bountra

  • David J. Kerr

  • Timothy M. Willson

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free